What is the recommended dosing for Orapred (prednisolone) in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Orapred (Prednisolone) in Children

The recommended dosing for Orapred (prednisolone) in children is 0.5-2 mg/kg/day with a maximum of 60 mg/day, with the specific dose depending on the condition being treated.

General Dosing Guidelines

Prednisolone dosing varies based on the specific condition being treated:

  • Initial dosing range: 0.14-2 mg/kg/day in three or four divided doses (4-60 mg/m² BSA/day) 1
  • Maximum dose: Generally capped at 60 mg/day for children 2
  • Administration: Typically given as a single morning dose to minimize hypothalamic-pituitary-adrenal axis suppression 2

Condition-Specific Dosing

Nephrotic Syndrome

  • Initial episode: 2 mg/kg/day (maximum 60 mg/day) 3, 2
  • Standard regimen: 60 mg/m²/day given in three divided doses for 4 weeks, followed by 4 weeks of single-dose alternate-day therapy at 40 mg/m²/day 1
  • Relapse treatment: 60 mg/m² daily until remission (urine dipstick trace/negative for at least 3 consecutive days), then 40 mg/m² on alternate days for 4 weeks with tapering 3

Asthma Exacerbations

  • Acute management: 1-2 mg/kg/day in single or divided doses (maximum 60 mg/day) until peak expiratory flow reaches 70% of predicted or personal best 3
  • Short course ("burst") therapy: 1-2 mg/kg/day for 3-10 days 3
  • Important note: No need to taper for courses less than 1 week; for courses up to 10 days, tapering is generally unnecessary if patients are concurrently taking inhaled corticosteroids 3

Viral Respiratory Infections

  • Lower airway disease: 2 mg/kg/day for 3 days has been shown effective in children 6-35 months 4

Formulation Considerations

Orapred is available as an oral solution (15 mg/5 mL) that has demonstrated better palatability compared to generic prednisolone:

  • Reduced vomiting: Studies show significantly less vomiting with Orapred (5.4%) compared to generic prednisolone (17.7%) 5
  • Better taste: Children report better taste scores with Orapred compared to generic prednisolone 5

Important Clinical Considerations

  • Duration of therapy: Should be individualized based on clinical response and the specific condition being treated
  • Tapering: For longer courses (>1 week), consider gradual tapering to prevent adrenal insufficiency 2
  • Monitoring: Regular monitoring is essential for all patients on long-term prednisolone therapy, including blood pressure, glucose levels, and growth in children 2
  • Steroid-sparing agents: Consider for patients who develop significant steroid-related adverse effects, especially in frequently relapsing conditions 3, 2

Cautions

  • Adverse effects: Monitor for osteoporosis, infections, cardiovascular events, and metabolic changes
  • Infections: Use with caution in patients with active infections
  • Live vaccines: Should be avoided during treatment
  • Abrupt discontinuation: Never stop prednisolone abruptly; always taper gradually to prevent adrenal insufficiency 2

Remember that dosing should be adjusted based on clinical response, and the lowest effective dose should be used to maintain remission while minimizing adverse effects.

References

Guideline

Corticosteroid Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.